Status | Study |
Recruiting |
Study Name: Efficacy and Safety Study of Mepolizumab in Subjects With Severe Hypereosinophilic Syndrome (HES) Condition: Hypereosinophilic Syndrome Date: 2016-07-14 Interventions: Drug: Mepolizumab 300 mg Mepol |
Recruiting |
Study Name: Eosinophilia Diagnosis Condition: Hypereosinophilic Syndrome Date: 2015-10-19 Interventions: Other: Scheduled exams and diagnosis Scheduled exams and diagnosis circuit as imposed by the algorithm |
Recruiting |
Study Name: Study to Evaluate Safety and Efficacy of Benralizumab in Subjects With Hypereosinophilic Syndrome Condition: Hypereosinophilic Syndrome Date: 2014-04-03 Interventions: Drug: benralizumab An afucosyl |
Active, not recruiting |
Study Name: Study to Evaluate Safety and Efficacy of Dexpramipexole (KNS-760704) in Subjects With Hypereosinophilic Syndrome Condition: Hypereosinophilic Syndrome Date: 2014-03-14 Interventions: Drug: Dexpramipexole Dexpramipexole (KNS 760704) is a synthetic amino-benzothiazole developed for use in |
Active, not recruiting |
Study Name: Identification of New Markers in the Hypereosinophilic Syndrome Condition: Hypereosinophilic Syndrome Date: 2012-10-22 Interventions: Biological: biologie sample comparison of biomarkers between HES, HE biomarkers data and control arms |
Active, not recruiting |
Study Name: Decitabine, Cytarabine, and Daunorubicin Hydrochloride in Treating Patients With Acute Myeloid Leukemia Condition: Adult Acute Basophilic Leukemia Adult Acute Eosinophilic Leukemia Date: 2012-06-21 Interventions: Drug: Cytarabine Given IV |
Terminated |
Study Name: Eltrombopag Olamine in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia Condition: Adult Acute Basophilic Leukemia Adult Acute Eosinophilic Leukemia Date: 2012-03-07 Interventions: Drug: eltrombopag olamine Give |
Recruiting |
Study Name: Steroid Treatment for Hypereosinophilic Syndrome Condition: Hypereosinophilia Date: 2012-02-01 Interventions: Drug: Corticosteroids |
Completed |
Study Name: Biomarkers in Bone Marrow Samples From Pediatric Patients With High-Risk Acute Myeloid Leukemia Condition: Childhood Acute Basophilic Leukemia Childhood Acute Eosinophilic Leukemia Date: 2010-02-25 Interventions: Other: laboratory biomarker analysis Correlative studies |
Completed |
Study Name: Efficacy of Imatinib Mesylate in Hypereosinophilic Syndromes Condition: Hypereosinophilic Syndrome Chronic Eosinophilic Leukemia Date: 2008-11-06 Interventions: Drug: Imatinib Patients received oral imatinib 100 mg/d; in case of unsatisfactory response (less than c |